12 Best Get Rich Quick Stocks to Buy According to Hedge Funds

10. Iovance Biotherapeutics Inc. (NASDAQ:IOVA)

Number of Hedge Fund Holders: 33

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is one of the best get-rich-quick stocks to buy according to hedge funds. On February 24, Iovance Biotherapeutics announced positive early data from a pilot clinical trial evaluating its lifileucel TIL cell therapy in patients with advanced soft tissue sarcomas. The study focused on individuals with metastatic or unresectable undifferentiated pleomorphic sarcoma/UPS and dedifferentiated liposarcoma/DDLPS who had failed at least one prior systemic treatment.

Among the first six evaluable patients, the therapy demonstrated a 50% objective response rate, with patients experiencing deep responses that improved over time despite a high baseline disease burden and multiple prior lines of therapy. Iovance Biotherapeutics Inc. (NASDAQ:IOVA) highlighted a significant unmet medical need for these aggressive cancers, which affect over 8,000 patients annually across the US and Europe. Current second-line treatment options typically yield response rates of less than 5%, with median overall survival often falling under one year.

Medical experts involved in the trial noted that this one-time immunotherapy treatment showed unprecedented results for refractory patients who previously relied on chemotherapy with limited efficacy. The safety profile observed in the study was favorable and remained consistent with lifileucel’s performance in other solid tumors like melanoma and lung cancer. Following these results, Iovance plans to launch a single-arm registrational trial for second-line advanced UPS and DDLPS in Q2 2026.

Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is a commercial-stage biopharmaceutical company that develops and commercializes cell therapies using autologous tumor-infiltrating lymphocytes for the treatment of metastatic melanoma and other solid tumor cancers in the US and internationally.